Zynex ROE 2006-2020 | ZYXI

Current and historical return on equity (ROE) values for Zynex (ZYXI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zynex ROE for the three months ending March 31, 2020 was 54.91%.
Zynex ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.01B $0.02B 54.79%
2019-12-31 $0.01B $0.02B 58.06%
2019-09-30 $0.01B $0.02B 70.59%
2019-06-30 $0.01B $0.01B 90.91%
2019-03-31 $0.01B $0.01B 105.26%
2018-12-31 $0.01B $0.01B 129.03%
2018-09-30 $0.01B $0.01B 148.15%
2018-06-30 $0.01B $0.01B 180.00%
2018-03-31 $0.01B $0.01B 360.00%
2017-12-31 $0.01B $0.01B 1400.00%
2017-09-30 $0.00B $0.00B -228.57%
2017-06-30 $0.00B $-0.00B -92.31%
2017-03-31 $0.00B $-0.00B -25.00%
2016-12-31 $0.00B $-0.00B -23.53%
2016-09-30 $0.00B $-0.00B 0.00%
2016-06-30 $-0.00B $-0.01B 25.00%
2016-03-31 $-0.00B $-0.00B 28.57%
2015-12-31 $-0.00B $-0.00B 66.67%
2015-09-30 $0.00B $-0.00B 0.00%
2015-06-30 $0.00B $-0.00B 0.00%
2015-03-31 $-0.01B $-0.00B 342.86%
2014-12-31 $-0.01B $-0.00B 1200.00%
2014-09-30 $-0.01B $-0.00B -1200.00%
2014-06-30 $-0.01B $-0.00B -346.67%
2014-03-31 $-0.01B $0.00B -133.33%
2013-12-31 $-0.01B $0.01B -88.89%
2013-09-30 $-0.00B $0.01B -27.91%
2013-06-30 $-0.00B $0.01B -17.39%
2013-03-31 $0.00B $0.01B 0.00%
2012-12-31 $0.00B $0.01B 0.00%
2012-09-30 $0.00B $0.01B 9.09%
2012-06-30 $0.00B $0.01B 19.51%
2012-03-31 $0.00B $0.01B 20.51%
2011-12-31 $0.00B $0.01B 22.22%
2011-09-30 $0.00B $0.01B 11.76%
2011-06-30 $0.00B $0.01B 0.00%
2011-03-31 $0.00B $0.01B 0.00%
2010-12-31 $0.00B $0.01B 0.00%
2010-09-30 $0.00B $0.01B 0.00%
2010-06-30 $0.00B $0.01B 0.00%
2010-03-31 $0.00B $0.01B 14.81%
2009-12-31 $0.00B $0.01B 32.00%
2009-09-30 $0.00B $0.01B 34.78%
2009-06-30 $0.00B $0.01B 33.33%
2009-03-31 $0.00B $0.01B 16.00%
2008-12-31 $0.00B $0.01B 0.00%
2008-09-30 $0.00B $0.01B 16.67%
2008-06-30 $0.00B $0.01B 42.11%
2008-03-31 $0.00B $0.01B 57.14%
2007-12-31 $0.00B $0.00B 72.73%
2007-09-30 $0.00B $0.00B 50.00%
2007-06-30 $0.00B $0.00B 0.00%
2007-03-31 $0.00B $0.00B 0.00%
2006-12-31 $0.00B $0.00B 0.00%
2006-09-30 $0.00B $0.00B 0.00%
2006-06-30 $0.00B $0.00B 0.00%
2006-03-31 $0.00B $0.00B nan%
2005-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.834B $0.045B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Stryker (SYK) United States $68.946B 22.38
Boston Scientific (BSX) United States $49.509B 23.28
Baxter (BAX) United States $44.233B 0.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.94
Zimmer Biomet Holdings (ZBH) United States $24.894B 15.66
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.589B 61.86
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 0.00
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.51
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.46
Owens & Minor (OMI) United States $0.464B 12.27
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
HEXO (HEXO) $0.322B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00